Eli Lilly’s ulcerative colitis drug approved by FDA in crowded market
Six months after rejecting Eli Lilly’s ulcerative colitis drug over manufacturing issues, the FDA has now approved the pharma giant …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
